Cargando…
1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782036/ http://dx.doi.org/10.1093/ofid/ofu052.788 |
| _version_ | 1783295098854834176 |
|---|---|
| author | Block, Stanley L. Christensen, Shane Verma, Bikash Xie, Fang Keshavan, Pavitra Dull, Peter M Smolenov, Igor |
| author_facet | Block, Stanley L. Christensen, Shane Verma, Bikash Xie, Fang Keshavan, Pavitra Dull, Peter M Smolenov, Igor |
| author_sort | Block, Stanley L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5782036 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57820362018-03-01 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination Block, Stanley L. Christensen, Shane Verma, Bikash Xie, Fang Keshavan, Pavitra Dull, Peter M Smolenov, Igor Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782036/ http://dx.doi.org/10.1093/ofid/ofu052.788 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Block, Stanley L. Christensen, Shane Verma, Bikash Xie, Fang Keshavan, Pavitra Dull, Peter M Smolenov, Igor 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination |
| title | 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination |
| title_full | 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination |
| title_fullStr | 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination |
| title_full_unstemmed | 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination |
| title_short | 1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination |
| title_sort | 1080 antibody persistence 5 years after vaccination at 2 to 10 years of age with quadrivalent menacwy-crm conjugate vaccine, and responses to a booster vaccination |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782036/ http://dx.doi.org/10.1093/ofid/ofu052.788 |
| work_keys_str_mv | AT blockstanleyl 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination AT christensenshane 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination AT vermabikash 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination AT xiefang 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination AT keshavanpavitra 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination AT dullpeterm 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination AT smolenovigor 1080antibodypersistence5yearsaftervaccinationat2to10yearsofagewithquadrivalentmenacwycrmconjugatevaccineandresponsestoaboostervaccination |